United Kingdom · Question · Written question
HL HL6784
Semaglutide: Artificial Intelligence
Introduced
23 April 2025
Last action
—
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
30 April 2025
Summary
To ask His Majesty's Government what assessment they have made of the (1) benefits and (2) risks of using wearable technology and AI-driven monitoring systems to track vital signs in patients who are prescribed semaglutide; and whether those systems could
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.